Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Q2 EBIT SEK 7.1 Million

July 11 (Reuters) - Xvivo Perfusion AB XVIVO.ST:

XVIVO Q2 EBIT SEK 7.1 MILLION

XVIVO Q2 EPS SEK 0.05

XVIVO Q2 NET INCOME SEK 1.6 MILLION

XVIVO Q2 ADJUSTED EBIT SEK 6.8 MILLION

XVIVO Q2 SALES SEK 178.3 MILLION

XVIVO PERFUSION AB - CONTINUE TO SEE STRONG SALES GROWTH IN LUNG AMONG US CUSTOMERS

XVIVO PERFUSION AB - SEE CONTINUED STRONG INTEREST IN INVESTING IN NEW EVLP AND LIVER PERFUSION PROGRAMS

Source text: ID:nMFN4C6Ktq

Further company coverage: XVIVO.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Xvivo Perfusion AB

See all news